Sector
PharmaceuticalsOpen
₹124Prev. Close
₹123.5Turnover(Lac.)
₹218.4Day's High
₹126Day's Low
₹117.3552 Week's High
₹12652 Week's Low
₹113.05Book Value
₹44.97Face Value
₹10Mkt Cap (₹ Cr.)
102.15P/E
23.62EPS
5.08Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|
Equity Capital | 0.78 | 0.7 | 0.7 |
Preference Capital | 0 | 0 | 0 |
Reserves | 5.61 | 1.29 | 0.23 |
Net Worth | 6.39 | 1.99 | 0.93 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.25 | 95.58 | 4,08,666.73 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,785.4 | 81.57 | 1,80,131.05 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,482.45 | 24.88 | 1,19,745.08 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,504.35 | 62.68 | 1,18,597.8 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,640.6 | 57.84 | 1,08,985.15 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Ashish Narayan Sakalkar
Whole Time Director & Chief Executive Officer
Saili Jayaram More
Non Executive Director
Sachin Chandrakant Badakh
Independent Director
Rishabh Kumar Jain
Independent Director
Vijaya Shahpurkar
Company Sec. & Compli. Officer
Vandana Mishra
4th Flr Office No.A-431 Balaji,
Bhavan Plot No.42A Sec-11 CBD,
Maharashtra - 400614
Tel: +91 22 4973 1411/+91 22 4973 1419
Website: http://www.asstonpharmaceuticals.com
Email: [email protected]
451 Krishna Apra Bus,
Netaji Subhash Place, Pitampura,
New Delhi-110034
Tel: 011-45121795
Website: www.maashitla.com
Email: [email protected]
Summary
Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as Asston Pharmaceutical Pvt. Limited to contract produce pharmaceutical products for export market. Later on 1st April 2024, Company...
Read More
Reports by Asston Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.